To investigate the role of integrin β3 and AXL in EGFR-TKI resistance in NSCLC, we compared the expression of integrin β3 and AXL in erlotinib-resistant and parental NSCLC cell lines. This evidence concerns the gene AXL and non-small cell lung carcinoma.